HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biochemical changes during goiter induction by methylmercaptoimidazol and inhibition by delta-iodolactone in rat.

AbstractBACKGROUND:
We have demonstrated that the administration of delta-iodolactone (i.e., 5-iodo-delta lactone) of arachidonic acid (IL-delta), a mediator in thyroid autoregulation, prevents goiter induction by methylmercaptoimidazol (MMI) in rats. Other studies have shown that transforming growth factor beta-1 (TGF-beta1) mimics some of the actions of excess iodide, but its participation in autoregulation is disputed. The present studies were performed to test the hypotheses that IL-delta decreases thyroid growth by inhibition of cell proliferation and/or by stimulation of apoptosis due to oxidative stress, that TGF-beta is stimulated by an excess of iodide and by IL-delta, and that c-Myc and c-Fos expression are upregulated during goiter induction and downregulated during goiter inhibition.
METHODS:
Rats were treated with MMI alone or together with iodide or IL-delta. Thyroid weight, cell number, cell proliferation, apoptosis, and oxidative stress were determined. Proliferating cell nuclear antigen (PCNA), TGF-beta1, TGF-beta3, c-Myc, and c-Fos were measured by Western blot.
RESULTS:
MMI caused a progressive increase in thyroid weight accompanied by an increase in cell number, asymmetry of the ploidy histograms, and PCNA, c-Fos, and c-Myc expression. In addition, an early increase of apoptosis was observed. Peroxides as well as glutathione peroxidase and catalase activities were also increased in goitrous animals. The inhibitory action of IL-delta on goiter formation was accompanied by the inhibition of cell proliferation evidenced by a significant decrease in cell number, PCNA expression, and asymmetry of the ploidy histograms. A transient stimulation of apoptosis after 7 days of treatment was also observed. MMI administration stimulated TGF-beta1 but not TGF-beta3 synthesis. IL-delta alone caused a slight increase of TGF-beta3 but not TGF-beta1, whereas potassium iodide (KI) stimulated both isoforms and MMI reversed KI effect on TGF-beta1 expression but not on TGF-beta3.
CONCLUSIONS:
The goiter inhibitory action of IL-delta is due to the inhibition of cell proliferation and the transient stimulation of apoptosis. This latter action does not involve oxidative stress. TGF-beta1 does not play a role in the autoregulatory pathway mediated by IL-delta. Iodide stimulates TGF-beta3 without the need of being organified. These results suggest that there may be more than one pathway involved in the autoregulatory mechanism.
AuthorsLisa Thomasz, Romina Oglio, Andrea S Randi, Marina Fernandez, María A Dagrosa, Romulo L Cabrini, Guillermo J Juvenal, Mario A Pisarev
JournalThyroid : official journal of the American Thyroid Association (Thyroid) Vol. 20 Issue 9 Pg. 1003-13 (Sep 2010) ISSN: 1557-9077 [Electronic] United States
PMID20825298 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 6-iodo-5-hydroxy-eicosatrienoic acid, delta-lactone
  • Arachidonic Acids
  • Peroxides
  • Proliferating Cell Nuclear Antigen
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-myc
  • Transforming Growth Factor beta1
  • Transforming Growth Factor beta3
  • Methimazole
  • Catalase
  • Glutathione Peroxidase
Topics
  • Animals
  • Apoptosis (drug effects)
  • Arachidonic Acids (therapeutic use)
  • Catalase (analysis)
  • Cell Proliferation (drug effects)
  • Female
  • Glutathione Peroxidase (analysis)
  • Goiter (chemically induced, prevention & control)
  • Methimazole (toxicity)
  • Oxidative Stress (drug effects)
  • Peroxides (analysis)
  • Proliferating Cell Nuclear Antigen (analysis)
  • Proto-Oncogene Proteins c-fos (analysis)
  • Proto-Oncogene Proteins c-myc (analysis)
  • Rats
  • Rats, Wistar
  • Thyroid Gland (drug effects, metabolism)
  • Transforming Growth Factor beta1 (analysis)
  • Transforming Growth Factor beta3 (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: